Private health insurance (PHI) is becoming an increasingly important access channel for pharma. As public funding comes under pressure, innovative therapies face greater reimbursement constraints, and international pricing dynamics evolve, manufacturers need to look beyond traditional public funding pathways.
At the same time, innovative therapies can create opportunities for insurers to differentiate their offerings, enhance value for members, and strengthen their proposition in an increasingly competitive market.
Join our upcoming Better Market Access webinar to explore where PHI can unlock meaningful access opportunities, what drives insurer coverage and partnership decisions, and how pharma and private payers can work together to build sustainable models that create value for patients, insurers, and manufacturers.
This webinar will cover:
- Why private health insurance matters
- How private insurers think and operate
- Where the most relevant access opportunities exist
- Which strategic questions manufacturers should be asking
Event details:
To accommodate different time zones, we are offering two sessions. This webinar is free of charge.
